Scholars Central

Conference abstract

Metabolic profile of endocrine resistance

Authors: Robert Clarke

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

About 70% of newly diagnosed cases of invasive breast cancer in the U.S. will be estrogen receptor ı positive (ER+). Endocrine therapy is the least toxic and most effective means to manage the hormone-dependent breast cancer in these patients, administered as an antiestrogen, e.g., Tamoxifen (TAM) or Faslodex (Fulvestrant; ICI 182,780) or an aromatase inhibitor (AI), e.g., Letrozole (LET). TAM produces a 26% proportional reduction in mortality; however, advanced ER+ breast cancer that has become resistant to endocrine therapy remains a significant clinical problem.We have shown that antiestrogen resistant breast cancer cells over-express X-Box Binding Protein 1 (XBP1) and glucose regulated protein-78 (GRP78;BiP), two integral signaling components of the unfolded protein response (UPR).XBP1 can regulate glucose homeostasis, and as glucose levels fall, GRP78 activates the UPR. Antiestrogen resistant breast cancer cells (MCF7/LCC9) utilize prosurvival UPR to maintain a higher level of basal autophagy compared to sensitive cells (MCF7/LCC1) that can provide raw materials to promote cell survival under stress from therapeutic insults. Abundance of metabolites from antiestrogen sensitive and resistant cells was compared and analyzed using UPLC-MS. Changes in selected metabolites were independently validated. Our findings indicate that resistant MCF7/LCC9 cells have an abundance of cAMP compared to MCF7/LCC1 cells. Glucose uptake in MCF/LCC9 control cells was 28-fold higherwhen compared to MCF7/LCC1 control cells, yet ATP levels in MCF7/LCC9 cells was 40% lower compared with MCF7/LCC1 control cells. cAMP has been recently identified as a potent inducer of autophagy. Our findings suggest that antiestrogen resistant breast cancer cells may have higher glucose (from the Warburg effect) and energy requirements, resulting in increased cAMPthat helps to maintain survival via autophagy under basal or treatment conditions. These metabolic adaptations are critical to the coordinated signaling from the UPR that both suppresses apoptosis and activates a prosurvival autophagy. Further studies will help to uncover the signaling mechanism involved in regulating the pathways that connect autophagy and metabolic pathways to maintain cell survival in resistance. The overall goal of this study is to provide more affordable diagnostic tools and to identify effective therapies and reliable biomarkers to predict accurately the response to antiestrogen therapy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Computer Science & Systems Biology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Computer Science & Systems Biology
  • SubjectComputer Science & IT
  • BylineArticles whose byline prints “Robert Clarke”